Yumei Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yumei Shen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Shanzhou Duan
Department of Thoracic Surgery, The Second Affiliated Hospital of SoochowUniversity, Suzhou, China
2 shared publications - Wei Fang
Department of Pathology, People’s Hospital of Chizhou, Chizhou, China
2 shared publications - Xiaoxiao Dai
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China
2 shared publications - Yifei Wang
Department of Thoracic Surgery, The Second Affiliated Hospital of SoochowUniversity, Suzhou, China
2 shared publications - Yongbing Chen
Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
2 shared publications - Yuanjun Cheng
Department of Thoracic Surgery, The Second Affiliated Hospital of SoochowUniversity, Suzhou, China
2 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1) , 1378
Publisher Correction: MISP promotes the progression of lung adenocarcinoma through inhibition of the Hippo signaling pathway
- 26 September 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1) , 1378
Open AccessPublisher Correction: MISP promotes the progression of lung adenocarcinoma through inhibition of the Hippo signaling pathway
- Open Access
- 17 November 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 2116
MISP promotes the progression of lung adenocarcinoma through Inhibition of the Hippo signaling pathway
Background Globally, lung cancer is a malignant tumor with the highest morbidity and mortality rate, of which lung adenocarcinoma (LUAD) is the most common pathological type, accounting for about 40% of all cases. This study aims to investigate the impact and molecular mechanisms of mitotic spindle positioning (MISP) on the occurrence and progression of LUAD. Methods The expression level of MISP were evaluated by qPCR and Western blotting. Hippo signaling-related protein levels were measured by Western blotting. Co-immunoprecipitation assay was applied to assess the interaction between MISP and MST1. The roles of MISP in LUAD cells were determined through CCK-8 assay, transwell migration/invasion assay, and flow cytometric analysis. A xenograft tumor model (n = 6) was established to calculate the effect of MISP in vivo. Results MISP expression was significantly higher in LUAD tissues compared to normal tissues. MISP overexpression promoted LUAD cell proliferation and migration in in vitro models, as well as tumor growth and metastasis in LUAD animal models. Western blotting demonstrated that MISP overexpression increased the expression of YAP, TAZ and CYR61, and decreased the expression of MST1 and phosphorylated YAP, thereby blocking the Hippo signaling pathway. While MISP knockdown had the opposite effect. Mechanistic experiments revealed that MISP directly interacts with MST1, thereby inhibiting Hippo signaling. Conclusions In conclusion, our study reveals a novel discovery that MISP promotes the growth and invasion of LUAD cells by interacting with MST1 and suppressing the Hippo pathway.
- 17 November 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 2116
Open AccessMISP promotes the progression of lung adenocarcinoma through Inhibition of the Hippo signaling pathway
Background Globally, lung cancer is a malignant tumor with the highest morbidity and mortality rate, of which lung adenocarcinoma (LUAD) is the most common pathological type, accounting for about 40% of all cases. This study aims to investigate the impact and molecular mechanisms of mitotic spindle positioning (MISP) on the occurrence and progression of LUAD. Methods The expression level of MISP were evaluated by qPCR and Western blotting. Hippo signaling-related protein levels were measured by Western blotting. Co-immunoprecipitation assay was applied to assess the interaction between MISP and MST1. The roles of MISP in LUAD cells were determined through CCK-8 assay, transwell migration/invasion assay, and flow cytometric analysis. A xenograft tumor model (n = 6) was established to calculate the effect of MISP in vivo. Results MISP expression was significantly higher in LUAD tissues compared to normal tissues. MISP overexpression promoted LUAD cell proliferation and migration in in vitro models, as well as tumor growth and metastasis in LUAD animal models. Western blotting demonstrated that MISP overexpression increased the expression of YAP, TAZ and CYR61, and decreased the expression of MST1 and phosphorylated YAP, thereby blocking the Hippo signaling pathway. While MISP knockdown had the opposite effect. Mechanistic experiments revealed that MISP directly interacts with MST1, thereby inhibiting Hippo signaling. Conclusions In conclusion, our study reveals a novel discovery that MISP promotes the growth and invasion of LUAD cells by interacting with MST1 and suppressing the Hippo pathway.